C63522Level 3

Regimen Used to Treat Malignant Ovarian Neoplasm

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** Any regimen that can be used for the treatment of malignant ovarian neoplasms.

GET/api/v1/systems/nci_thesaurus/nodes/C63522

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C10058Altretamine/Cisplatin/Cyclophosphamide/Fluorouracil Regimen

C128248PEB Regimen

C138050Bevacizumab/Paclitaxel Regimen

C156262Carboplatin/Liposomal Doxorubicin Regimen

C159987Altretamine Regimen

C159988Anastrozole Regimen

C160014Cyclophosphamide Regimen

C160025Doxorubicin Regimen

C160035Exemestane Regimen

C160041Fulvestrant Regimen

C160044Goserelin Regimen

C160078Letrozole Regimen

C160079Leuprolide Acetate Regimen

C160080Liposomal Doxorubicin Regimen

C160084Melphalan Regimen

C160097Olaparib Regimen

C160099Etoposide Oral Regimen

C160121Tamoxifen Regimen

C160129Topotecan Daily Regimen

C160502Ifosfamide/Paclitaxel Regimen

C160508Cisplatin/Paclitaxel/Intraperitoneal Paclitaxel Regimen

C160525Bevacizumab/Liposomal Doxorubicin Regimen

C160536Bevacizumab/Topotecan Regimen

C160552Bevacizumab/Carboplatin/Gemcitabine Regimen

C160807Niraparib Regimen

C160812Rucaparib Regimen

C161916Carmustine/Cyclophosphamide/Doxorubicin Regimen

C161942CAC Regimen

C161947CIM Regimen

C161993PMF Regimen

C162004DDP-MECY Regimen

C172134Bevacizumab/Olaparib Regimen

C187137Sorafenib/Topotecan Regimen

C189664Bevacizumab/Niraparib Regimen

C192824Bevacizumab/Carboplatin/Liposomal Doxorubicin Regimen

C192895Bevacizumab/Carboplatin/Docetaxel Regimen

C192896Bevacizumab/Ixabepilone Regimen

C192897Bevacizumab/Mirvetuximab Soravtansine Regimen

C203695Mirvetuximab Soravtansine Regimen

C204447Bevacizumab/Docetaxel/Oxaliplatin Regimen

C205258Intraperitoneal Carboplatin/Paclitaxel Regimen

C205282Intraperitoneal Carboplatin/Paclitaxel/Intraperitoneal Paclitaxel Regimen

C205404Bevacizumab/Cyclophosphamide/Pembrolizumab Regimen

C205405Bevacizumab/Carboplatin/Docetaxel Followed by Bevacizumab Regimen

C205408Bevacizumab/Docetaxel/Oxaliplatin Followed by Bevacizumab Regimen

C205461Bevacizumab/Gemcitabine Regimen

C210802Bevacizumab/Carboplatin/Paclitaxel Followed by Bevacizumab Regimen

C210803Intraperitoneal Cisplatin/Paclitaxel/Intraperitoneal Paclitaxel Regimen

C217091Avutometinib and Defactinib Regimen

C225004Bevacizumab/Paclitaxel/Pembrolizumab Regimen

C225005Berahyaluronidase Alfa and Pembrolizumab/Bevacizumab/Paclitaxel Regimen

C225006Berahyaluronidase Alfa and Pembrolizumab/Paclitaxel Regimen

C226492Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Vinblastine Regimen

C63488BEP Regimen

C63789Liposomal Doxorubicin/Gemcitabine Regimen

C67289JEB Regimen

C9511AcFuCy Regimen

C9532Carboplatin/Cyclophosphamide Regimen

C9569Cisplatin/Cyclophosphamide Regimen

C9570CHAD Regimen

C9598Hexa-CAF Regimen

C9626Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin Regimen

C9812Carboplatin/Cisplatin/Cyclophosphamide Regimen

C9907Bleomycin/Cyclophosphamide/Doxorubicin/Mitomycin Regimen

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue